1.1.1
Treat an acute painful sickle cell episode as an acute medical emergency. Follow locally agreed protocols for managing acute painful sickle cell episodes and/or acute medical emergencies that are consistent with this guideline.
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care.
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.
NICE has produced a guideline on babies, children and young people's experience of healthcare.
Treat an acute painful sickle cell episode as an acute medical emergency. Follow locally agreed protocols for managing acute painful sickle cell episodes and/or acute medical emergencies that are consistent with this guideline.
Throughout an acute painful sickle cell episode, regard the patient (and/or their carer) as an expert in their condition, listen to their views and discuss with them:
the planned treatment regimen for the episode
treatment received during previous episodes
any concerns they may have about the current episode
any psychological and/or social support they may need.
Assess pain and use an age-appropriate pain scoring tool for all patients presenting at hospital with an acute painful sickle cell episode.
Offer analgesia within 30 minutes of presentation to all patients presenting at hospital with an acute painful sickle cell episode (see also the recommendations on primary analgesia).
Clinically assess all patients presenting at hospital with an acute painful sickle cell episode, including monitoring of:
blood pressure
oxygen saturation on air (if oxygen saturation is 95% or below, offer oxygen therapy)
pulse rate
respiratory rate
temperature.
Be aware that some pulse oximeters can underestimate or overestimate oxygen saturation levels, especially if the saturation level is borderline. Overestimation has been reported in people with dark skin. See also the NHS England Patient Safety Alert on the risk of harm from inappropriate placement of pulse oximeter probes.
Assess all patients with sickle cell disease who present with acute pain to determine whether their pain is being caused by an acute painful sickle cell episode or whether an alternative diagnosis is possible, particularly if pain is reported as atypical by the patient.
When offering analgesia for an acute painful sickle cell episode:
ask about and take into account any analgesia taken by the patient for the current episode before presentation
ensure that the drug, dose and administration route are suitable for the severity of the pain and the age of the patient
refer to the patient's individual care plan if available.
Offer a bolus dose of a strong opioid by a suitable administration route, in accordance with locally agreed protocols for managing acute painful sickle cell episodes, to:
all patients presenting with severe pain
all patients presenting with moderate pain who have already had some analgesia before presentation.
Consider a weak opioid as an alternative to a strong opioid for patients presenting with moderate pain who have not yet had any analgesia.
Offer all patients regular paracetamol and NSAIDs (non-steroidal anti-inflammatory drugs) by a suitable administration route, in addition to an opioid, unless contraindicated.
The use of NSAIDs should be avoided during pregnancy, unless the potential benefits outweigh the risks. NSAIDs should be avoided for treating an acute painful sickle cell episode in women in the third trimester. See the BNF for details of contraindications.
Do not offer pethidine for treating pain in an acute painful sickle cell episode.
Assess the effectiveness of pain relief:
every 30 minutes until satisfactory pain relief has been achieved, and at least every 4 hours thereafter
using an age-appropriate pain scoring tool
by asking questions, such as:
How well did that last painkiller work?
Do you feel that you need more pain relief?
If the patient has severe pain on reassessment, offer a second bolus dose of a strong opioid (or a first bolus dose if they have not yet received a strong opioid).
Consider patient-controlled analgesia if repeated bolus doses of a strong opioid are needed within 2 hours. Ensure that patient-controlled analgesia is used in accordance with locally agreed protocols for managing acute painful sickle cell episodes and/or acute medical emergencies.
Offer all patients who are taking an opioid:
laxatives on a regular basis
anti-emetics as needed
antipruritics as needed.
Monitor patients taking strong opioids for adverse events, and perform a clinical assessment (including sedation score):
every 1 hour for the first 6 hours
at least every 4 hours thereafter.
If the patient does not respond to standard treatment for an acute painful sickle cell episode, reassess them for the possibility of an alternative diagnosis.
As the acute painful sickle cell episode resolves, follow locally agreed protocols for managing acute painful sickle cell episodes to step down pharmacological treatment, in consultation with the patient.
Be aware of the possibility of acute chest syndrome in patients with an acute painful sickle cell episode if any of the following are present at any time from presentation to discharge:
abnormal respiratory signs and/or symptoms
chest pain
fever
signs and symptoms of hypoxia:
oxygen saturation of 95% or below or
an escalating oxygen requirement.
Be aware that some pulse oximeters can underestimate or overestimate oxygen saturation levels, especially if the saturation level is borderline. Overestimation has been reported in people with dark skin. See also the NHS England Patient Safety Alert on the risk of harm from inappropriate placement of pulse oximeter probes.
Be aware of other possible complications seen with an acute painful sickle cell episode, at any time from presentation to discharge, including:
acute stroke
aplastic crisis
infections
osteomyelitis
splenic sequestration.
Do not use corticosteroids in the management of an uncomplicated acute painful sickle cell episode.
Encourage the patient to use their own coping mechanisms (for example, relaxation techniques) for dealing with acute pain.
All healthcare professionals who care for patients with an acute painful sickle cell episode should receive regular training, with topics including:
pain monitoring and relief
the ability to identify potential acute complications
attitudes towards and preconceptions about patients presenting with an acute painful sickle cell episode.
Where available, use day care settings in which staff have specialist knowledge and training for the initial assessment and treatment of patients presenting with an acute painful sickle cell episode.
All healthcare professionals in emergency departments who care for patients with an acute painful sickle cell episode should have access to locally agreed protocols and specialist support from designated centres.
Patients with an acute painful sickle cell episode should be cared for in an age-appropriate setting.
For pregnant women with an acute painful sickle cell episode, seek advice from the obstetrics team and refer when indicated.
Before discharge, provide the patient (and/or their carer) with information on how to continue to manage the current episode, including:
how to obtain specialist support
how to obtain additional medication
how to manage any potential side effects of the treatment they have received in hospital.
Pain with a Visual Analogue Scale (VAS; or equivalent) score typically within the range of 4 to 7 (this description should not be interpreted as a strict definition and will not apply to all patients, as pain is subjective).
A method of safely administering strong opioids which is controlled by the patient (or a nurse for nurse-controlled analgesia).
Pain with a VAS (or equivalent) score typically above 7 (this description should not be interpreted as a strict definition and will not apply to all patients, as pain is subjective).